NCT00546533View on ClinicalTrials.gov

Study Evaluating the Efficacy and Safety of Etanercept

PHASE4CompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

January 31, 2003

Study Completion Date

February 28, 2005

Conditions

Rheumatoid Arthritis

Interventions

DRUG

Etanercept

All Listed Sponsors

lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00546533 - Study Evaluating the Efficacy and Safety of Etanercept | Biotech Hunter | Biotech Hunter